TY - CHAP M1 - Book, Section TI - Iliac Artery Occlusive Disease, Endovascular Stenting A1 - Ellison, E. Christopher A1 - Zollinger, Jr., Robert M. A1 - Pawlik, Timothy M. A1 - Vaccaro, Patrick S. A1 - Bitans, Marita A1 - Baker, Anthony S. PY - 2022 T2 - Zollinger’s Atlas of Surgical Operations, 11e AB - Patients with iliac artery stenosis often will have concomitant lower extremity or aortic peripheral arterial disease. Isolated iliac occlusive disease typically produces ipsilateral hip, thigh, or buttock claudication, whereas when found concomitantly with superficial femoral or tibial occlusive disease, it can manifest as limb-threatening ischemia (rest pain, nonhealing wounds, or gangrene). When to intervene on an isolated iliac artery stenosis depends on the degree of patient symptoms and patient risk factors, which may increase the risk of an intervention. A trial of cilastazol can be instituted first but typically is not as successful in the face of isolated iliac artery occlusive disease. Modification of atherosclerotic risk factors should be undertaken as soon as recognized in order to improve long-term patient outcomes. This may include smoking cessation, hypertension control, lipid profile improvement, and diabetes management. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/28 UR - accesssurgery.mhmedical.com/content.aspx?aid=1187824718 ER -